What was the comprehensive income (loss) for Remax for the year ended December 31, 2022?
Remax Franchise · 2025 FDDAnswer from 2025 FDD Document
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 2023 | 2022 | |||||
| Revenue: | ||||||
| Continuing franchise fees | $ | 122,011 | $ | 127,384 | $ | 133,389 |
| Annual dues | 32,188 | 33,904 | 35,676 | |||
| Broker fees | 51,816 | 51,012 | 62,939 | |||
| Marketing Funds fees | 78,983 | 83,861 | 90,319 | |||
| Franchise sales and other revenue | 22,687 | 29,510 | 31,063 | |||
| Total revenue | 307,685 | 325,671 | 353,386 | |||
| Operating expenses: | ||||||
| Selling, operating and administrative expenses | 143,267 | 160,972 | 164,871 | |||
| Marketing Funds expenses | 78,983 | 83,861 | 90,319 | |||
| Depreciation and amortization | 29,551 | 32,387 | 35,742 | |||
| Settlement and impairment charges | 5,483 | 73,783 | 15,80 |
Source: Item 22 — Contracts (FDD pages 108–334)
What This Means (2025 FDD)
According to Remax's 2025 Franchise Disclosure Document, the comprehensive income (loss) for the year ended December 31, 2022, was $18,024. This figure represents the net income (loss) adjusted for changes in cumulative translation adjustments and other comprehensive income (loss), net of tax.
For a prospective franchisee, understanding comprehensive income is crucial as it provides a broader view of Remax's financial performance beyond just net income. It includes items that are not typically reflected in the income statement but still impact the company's overall financial health. A positive comprehensive income suggests that the company is not only profitable but also experiencing gains in other areas, such as foreign currency translation.
It's important to note that while net income is a key indicator, comprehensive income offers a more complete picture of Remax's financial stability. Franchisees should review these figures in conjunction with other financial statements and consult with a financial advisor to fully assess the franchisor's financial health and stability.